Read More »
Diabetes In Control
Self-Assessment Improves Diabetes Screening
Self-Assessment Improves Diabetes Screening A simple questionnaire on lifestyle, age, and health history could improve widespread diabetes screening efforts, researchers said. The self-assessment score selected out 35% of screened persons as high risk, with a sensitivity of 79% and specificity of 67%, Heejung Bang, PhD, of Weill Cornell Medical College …
Read More »Dark Chocolate Eases Emotional Stress
Dark Chocolate Eases Emotional Stress: The “chocolate cure” for emotional stress is getting new support from a clinical trial. The study found that eating about an ounce and a half of dark chocolate a day for two weeks reduced levels of stress hormones in the bodies of people feeling highly stressed. …
Read More »Prevalence of High LDL Cholesterol Levels Decreases in U.S.
Prevalence of High LDL Cholesterol Levels Decreases in U.S.: Between 1999 and 2006, the prevalence of adults in the U.S. with high levels of LDL cholesterol, the “bad” cholesterol, decreased by about one-third, according to a study. But a high percentage of adults still are not screened or treated for …
Read More »Sulfonylureas Increase Risks of Death and Heart Failure
Sulfonylureas Increase Risks of Death and Heart Failure: Sulfonylurea monotherapy for Type 2 diabetes was associated with increased risks of all-cause death and congestive heart failure compared with metformin, a large, retrospective study showed. Through a mean follow-up of 7.1 years, both first-generation and second-generation sulfonylureas were associated with elevated …
Read More »One in Five Type 2’s Is “Morbidly Obese” — 100 or More Pounds Overweight
One in Five Type 2’s Is “Morbidly Obese” — 100 or More Pounds Overweight: Researchers reported that 62.4 percent of U.S. adults with Type 2 diabetes are obese, and 20.7 percent are morbidly obese. Among African American adults with Type 2 diabetes, 1 in 3 is morbidly obese. “The rate …
Read More »Higher Risks of Death and Heart Failure Tied to Sulfonylureas
Sulfonylurea monotherapy for Type 2 diabetes was associated with increased risks of all-cause death and congestive heart failure compared with metformin, a large, retrospective study showed.
Read More »Low Reimbursement for Diabetes Care Hurts Patients
In a survey of 200 primary care physicians and 100 endocrinologists, 32% reported an inability to provide comprehensive diabetes care. Almost one-third of doctors in an industry-sponsored survey said they didn’t spend enough time with their diabetes patients and blamed low reimbursement rates for diabetes care, researchers said.
Read More »Dysglycemia and Progression to Type 1 Diabetes
Incident dysglycemia in those who are ICA positive is strongly predictive of Type 1 diabetes. Children with incident dysglycemia have an especially high risk.
Read More »Update on Generex Oral-lyn
An independent review of clinical trials of Generex Oral-lyn(TM) shows that the oral insulin spray has a faster onset of action and shorter duration of action than insulin delivered subcutaneously.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.